News & Updates
Showing Urology articles
Showing

CKD patients more prone to tuberculosis
Patients with stage 5 chronic kidney disease (CKD5) are at greater risk of developing tuberculosis (TB) than the general population, especially if they are male or receiving dialysis, suggests a Singapore study.
CKD patients more prone to tuberculosis
30 Mar 2026
Antibiotics, low-yield investigations for recurrent UTI prevail in real-world practice
Recurrent urinary tract infection (UTI) care in primary and secondary care settings appears to be characterized by low guideline adherence, with a substantial number of women still being treated with antibiotics and subjected to low-yield investigations, according to a study.
Antibiotics, low-yield investigations for recurrent UTI prevail in real-world practice
29 Mar 2026
Mirabegron a potentially safer alternative to solifenacin for paediatric OAB
In the treatment of overactive bladder (OAB) in children, mirabegron demonstrates efficacy similar to that of solifenacin but has a better safety profile, according to a meta-analysis presented at the annual EAU Congress.
Mirabegron a potentially safer alternative to solifenacin for paediatric OAB
28 Mar 2026
2-year data support nerve-sparing technique in prostate cancer surgery
An updated 24-month analysis of the NeuroSAFE PROOF study continues to support robot-assisted radical prostatectomy (RARP) guided by the nerve-sparing NeuroSAFE technique in men with prostate cancer.
2-year data support nerve-sparing technique in prostate cancer surgery
27 Mar 2026
Pre-TURBT mitomycin-C improves RFS in NMIBC
In the updated 5-year analysis of a randomized phase II trial, administering two doses of intravesical mitomycin-C (MMC) immediately before transurethral resection of bladder tumour (TURBT) improves recurrence-free survival (RFS) in individuals with non-muscle invasive bladder cancer (NMIBC).




